Marlow Hernandez - Aug 16, 2021 Form 4/A - Amendment Insider Report for Cano Health, Inc. (CANO)

Signature
/s/ David Armstrong, Attorney-in-Fact for Marlow Hernandez
Stock symbol
CANO
Transactions as of
Aug 16, 2021
Transactions value $
$2,747,800
Form type
4/A - Amendment
Date filed
8/23/2021, 08:05 AM
Date Of Original Report
Aug 18, 2021
Previous filing
Jun 14, 2021
Next filing
Aug 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Purchase $1.22M +120K $10.16* 120K Aug 16, 2021 Direct F1
transaction CANO Class A Common Stock Purchase $860K +90K +75% $9.55* 210K Aug 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CANO Warrants to purchase Class A Common Stock Purchase $443K +160K $2.77* 160K Aug 16, 2021 Class A Common Stock 160K $11.50 Direct F3
transaction CANO Warrants to purchase Class A Common Stock Purchase $226K +90K +56.25% $2.51* 250K Aug 17, 2021 Class A Common Stock 90K $11.50 Direct F4
holding CANO Class B Common Stock 22M Aug 16, 2021 Class A Common Stock 22M See Footnote F5, F6
holding CANO PCIH Common Units 22M Aug 16, 2021 Class A Common Stock 22M See Footnote F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.05 to $10.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.34 to $9.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.70 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.40 to $2.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F5 Common limited liability company units of Primary Care (ITC) Intermediate Holdings, LLC ("PCIH Common Units"), together with an equal number of shares of the Issuer's Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), are exchangeable for either cash or shares of Class A Common Stock on a one-for-one basis. The PCIH Common Units have no expiration date.
F6 The Class B Common Stock and PCIH Common Units are owned indirectly by the reporting person through Hernandez Borrower Holdings, LLC. The reporting person has sole voting and dispositive power with respect to all of the securities held by Hernandez Borrower Holdings, LLC and therefore is the beneficial owner of these securities.